<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ACETYLCYSTEINE <img border="0" src="../images/pr.gif"/></span><br/>(a-se-til-sis'tay-een)<br/><span class="topboxtradename">Airbron <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename"> Mucomyst, </span><span class="topboxtradename"> Mucosol, </span><span class="topboxtradename">
<i>N</i>-Acetylcysteine, </span><span class="topboxtradename"> Acetadote, </span><span class="topboxtradename">Acys-5<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">mucolytic</span>; <span class="classification">antidote</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10%, 20% solution for inhalation; 20% solution for injection</p>
<h1><a name="action">Actions</a></h1>
<p>Acetylcysteine probably acts by disrupting disulfide linkages of mucoproteins in purulent and nonpurulent secretions.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Acetylcysteine lowers viscosity and facilitates the removal of secretions.</p>
<h1><a name="uses">Uses</a></h1>
<p>Adjuvant therapy in patients with abnormal, viscid, or inspissated mucous secretions in acute and chronic bronchopulmonary
         diseases, and in pulmonary complications of cystic fibrosis and surgery, tracheostomy, and atelectasis. Also used in diagnostic
         bronchial studies and as an antidote for acute acetaminophen poisoning.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>As an ophthalmic solution for treatment of dry eye (keratoconjunctivitis sicca); as an enema to treat bowel obstruction due
         to meconium ileus; prevention of radiocontrast-induced renal dysfunction.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to acetylcysteine; patients at risk of gastric hemorrhage.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with asthma, older adults, severe hepatic disease, esophageal varices, peptic ulcer disease; debilitated patients
         with severe respiratory insufficiency, pregnancy (category B), lactation.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mucolytic</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Inhalation</span> 110 mL of 20% solution q46h or 220 mL of 10% solution q46h <span class="rdroute">Direct Instillation</span> 12 mL of 1020% solution q14h<br/><span class="rdage">Child:</span> <span class="rdroute">Inhalation</span> 35 mL of 20% solution or 610 mL of 10% solution 34 times/d<br/><span class="rdage">Infant:</span> <span class="rdroute">Inhalation</span> 12 mL 20% solution or 24 mL of 10% solution 34 times/d<br/><br/><span class="indicationtitle">Acetaminophen Toxicity</span><br/><span class="rdage">Adult/Child:</span> <span class="rdroute">PO</span> 140 mg/kg followed by 70 mg/kg q4h for 17 doses (use a 5% solution)<br/><span class="rdage">Adult/Adolescent:</span> <span class="rdroute">IV</span> 150 mg/kg infused over 15 min, followed by 50 mg/kg over 4 h, then 100 mg/kg over 16 h; OR 140 mg/kg infused over 1 h, then,
               4 h after the loading dose, give 70 mg/kg q4h <small>x</small> 12 doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation and Instillation</span><br/><ul>
<li>Prepare dilution within 1 h of use; drug does not contain an antimicrobial agent. A light purple discoloration does not significantly
            impair drug's effectiveness.
         </li>
<li>Dilute the 20% solution with NS or water for injection. The 10% solution may be used undiluted.</li>
<li>Give by direct instillation into tracheostomy (12 mL of 1020% solution).</li>
<li>Instruct patient to clear airway, if possible, coughing productively prior to aerosol administration to ensure maximum effect.</li>
<li>Store opened vial in refrigerator to retard oxidation; use within 96 h.</li>
<li>Store unopened vial at 15°30° C (59°86° F), unless otherwise directed.</li>
</ul><span class="adminroutetype">Oral</span><br/><ul>
<li>Dilute the 20% solution 1:3 with cola, orange juice, or other soft drink to make a 5% solution. If administered via
            a gastric tube, water may be used as the diluent.
         </li>
<li>Freshly prepare all diluted solutions and use within 1 hour of preparation.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span>  Acetylcysteine reacts with certain metals and rubber; use IV equipment made of plastic or glass. Dilute all required doses
                  in D5W as follows: for loading dose, add a dose equal to 150 mg/kg to 200 mL; for first maintenance dose, add a dose equal
                  to 50 mg/kg to 500 mL; for second maintenance dose, add a dose equal to 100 mg/kg to 1000 mL. Note: The total IV volume should be reduced for patients 
               </p><p><span class="routemethod">ADMINISTER:</span> <span class="methodtype"> IV Infusion:</span>  Give loading dose over 15 min, maintenance dose 1 over 4 h, maintenance dose 2 over 16 h.  
               </p>
</td>
</tr>
</table>
<ul>
<li>Store reconstituted solution for up to 24 h at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Dizziness, drowsiness. <span class="typehead">GI:</span> Nausea, <span class="speceff-common">vomiting,</span> stomatitis, hepatotoxicity (urticaria). <span class="typehead">Respiratory:</span>
<span class="speceff-life">Bronchospasm</span>, rhinorrhea, burning sensation in upper respiratory passages, epistaxis. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Onset:</span> 1 min after inhalation or instillation. <span class="typehead">Peak:</span> 510 min. <span class="typehead">Metabolism:</span> Deacetylated in liver to cysteine and subsequently metabolized. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>During IV infusion, carefully monitor for fluid overload and signs of hyponatremia (i.e., changes in mental status).</li>
<li>Monitor for S&amp;S of aspiration of excess secretions, and for bronchospasm (unpredictable); withhold drug and notify physician
            immediately if either occurs.
         </li>
<li>Lab tests: Monitor ABGs, pulmonary functions and pulse oximetry as indicated.</li>
<li>Have suction apparatus immediately available. Increased volume of respiratory tract fluid may be liberated; suction or endotracheal
            aspiration may be necessary to establish and maintain an open airway. Older adults and debilitated patients are particularly
            at risk.
         </li>
<li>Nausea and vomiting may occur, particularly when face mask is used, due to unpleasant odor of drug and excess volume of liquefied
            bronchial secretions.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report difficulty with clearing the airway or any other respiratory distress.</li>
<li>Report nausea, as an antiemetic may be indicated.</li>
<li>
            							Note: Unpleasant odor of inhaled drug becomes less noticeable with continued use.
            						
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>